222
Participants
Start Date
December 18, 2015
Primary Completion Date
May 25, 2020
Study Completion Date
February 1, 2022
Ipilimumab
Induction phase: i.v. 3 mg/kg, once every 3 weeks × 4 cycles, to start within 6-8 weeks (42-56 days) from start of chemotherapy cycle 4, and not more than 2 weeks (14 days) after the date of randomisation)
Nivolumab
Induction phase: Nivolumab i.v. 1 mg/kg, once every 3 weeks × 4 cycles, to start within 6-8 weeks (42-56 days) from start of chemotherapy cycle 4, and not more than 2 weeks (14 days) after the date of randomisation) Maintenance Phase: Nivolumab 240 mg i.v once every 2 weeks for a maximum of 12 months from start of maintenance (the first dose of maintenance nivolumab will be administered 3 weeks after the last IMP doses of induction Phase).
University Hospital Gasthuisberg, KU Leuven, Leuven
LungenClinic Grosshansdorf GmbH, Großhansdorf
Centre Hospitalier Général, Le Mans
Bendigo Hospital, Bendigo
Coffs Harbour Health Campus, Coffs Harbour
Royal Brisbane and Women's Hospital (QLD), Herston
Royal Hobart Hospital, Hobart
NNSWLHD - The Tweed Hospital, Lismore
Austin Hospital, Melbourne
Riverina Cancer Centre, Mount Kuring-Gai
Port Macquarie Base Hospital, Port Macquarie
Epworth HealthCare - Richmond, Richmond
Princess Alexandra Hospital, Woolloongabba
Avignon - Institut Sainte-Catherine, Avignon
Caen - Centre François Baclesse, Caen
CHU, Caen
Percy/Armées, Clamart
Clermont-Ferrand, Clermont-Ferrand
Créteil - CHI, Créteil
CHU, Grenoble
Hôpital Louis Pradel, Lyon
Lyon - Sud, Lyon
AP-HM, Marseille
Centre Hospitalier Universitaire de Montpellier, Montpellier
CH, Mulhouse
CRLCC, Nantes
Nice - CRLCC, Nice
Orléans - CH, Orléans
Paris - Bichat, Paris
Paris - Saint-Louis, Paris
Paris - Tenon, Paris
CHU, Rennes
Nouvel Hôpital Civil, Strasbourg
Suresnes, Suresnes
CHI, Toulon
CHU, Toulouse
CHU, Tours
Institut Gustave Roussy, Villejuif
Klinikum Esslingen, Esslingen am Neckar
Klinikum München-Bogenhausen, München
Thoracic Oncology Centre Munich, München
Pius-Hospital Oldenburg, Oldenburg
Krankenhaus der Barmherzigen Brüder, Trier
Universitätsklinikum Tübingen, Tübingen
VUMC, Amsterdam
Maastro Clinic, Maastricht
Hospital General Universitario Alicante, Alicante
Hospital Universitario Cruces, Barakaldo
Hospital De La Santa Creu I Sant Pau, Barcelona
Clinico San Carlos, Madrid
Hospital Puerta de Hierro, Madrid
Hospital Universitario 12 Octubre, Madrid
Hospital Universitario Fundacion Jimenez Díaz, Madrid
Hospital Universitario Central De Asturias, Oviedo
Hospital Virgen De La Salud, Toledo
Hospital Clínico Universitario De Valencia, Valencia
Centre Hospitalier Universitaire Vaudois, Lausanne
University Hospital Zürich, Zurich
St James' University Hospital, Leeds
Royal Marsden, London
The Christie NHS Foundation Trust, Manchester
Collaborators (1)
Intergroupe Francophone de Cancerologie Thoracique
OTHER
Ludwig Center for Cancer Research of Lausanne
OTHER
Frontier Science Foundation, Hellas
OTHER
Bristol-Myers Squibb
INDUSTRY
ETOP IBCSG Partners Foundation
NETWORK